{"id":"W2916635613","doi":"10.1182/blood-2018-99-112076","title":"Alemtuzumab Added to CHOP for Treatment of Peripheral T-Cell Lymphoma (PTCL) in Previously Untreated Young and Elderly Patients: Pooled Analysis of the International ACT-1/2 Phase III Trials","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; CHOP; Alemtuzumab; Internal medicine; Clinical endpoint; Interim analysis; Progression-free survival; Surgery; Randomized controlled trial; Lymphoma; Chemotherapy; Transplantation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0167726,0.001301102,0.004701656,0.001228158,0.0002034997,0.001635716,0.0005287822,0.0009966965,0.001094228],"category_scores_gemma":[0.01130646,0.0004707292,0.009211976,0.001594709,0.0004128072,0.0006652799,0.0006608089,0.0009315836,0.0001385765],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005804026,"about_ca_system_score_gemma":0.0008138977,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005418352,"about_ca_topic_score_gemma":0.001185114,"domain_scores_codex":[0.9894496,0.008152482,0.001082472,0.0005858842,0.0005325306,0.0001970361],"domain_scores_gemma":[0.9933162,0.003180779,0.002231558,0.0004826936,0.0004397013,0.0003490279],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.58341,0.0004798692,0.02103584,0.008922546,0.3394719,0.0001319641,0.00008366547,0.002129602,0.002589977,0.0001335912,0.001218253,0.04039275],"study_design_scores_gemma":[0.1981611,0.04668301,0.08664357,0.001973331,0.6567476,0.000311409,0.0001165564,0.002230313,0.001788915,0.0005080053,0.00474014,0.00009601806],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.628166,0.359861,0.003545225,0.0006021873,0.0006760453,0.002064382,0.002631279,0.000105018,0.002348908],"genre_scores_gemma":[0.9729692,0.02102381,0.001662602,0.000543013,0.000467884,0.001291238,0.001626446,0.00002711481,0.0003886967],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0167726,"threshold_uncertainty_score":0.08870304,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0197811737049774,"score_gpt":0.3063851743890686,"score_spread":0.2866040006840912,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}